Massimo Massi Benedetti
Prof. Dr. Eberhard Standl
Andrew JM Boulton
Jean Claude Mbanya
Abdullah Al Zakwani
Abdulmoein Eid Al-Agha
Bassam Saleh Bin-Abbas
Ebaa Al Ozairi
Saad Al Zahrani
Consultant Endocrinologist & Internist
East Jeddah Hospital, Jeddah,
Dr.Al Juhani a consultant internist & endocrinologist & the chief of internal medicine at
East Jeddah hospital (300-bed capacity, JCI-accredited), Jeddah, KSA.Aljuhani was
graduated 1994 from King Abdulaziz university, Jeddah, KSA. He completed his
fellowship program in endocrinology & metabolism at King Faisal specialist hospital &
research center, Riyadh, KSA, 2004.
He had been working at King Abdul-Aziz Hospital & Oncology center ( KAAH&OC) (450-bed capacity) MOH, JCI-accredited hospitals, Jeddah, KSA as consultant endocrinologist & internist from 2004 to 2012. He was appointed as Assistant supervisor general for medical affair (Medical director) & chief of internal medicine at king Abdul- Aziz Hospital & Oncology center ( KAAH&OC), Jeddah, KSA 2008-2012 then he was appointed as the Director of AL-Thagar General Hospital, Jeddah, KSA from 2012 till 2016 & Supervisor General of New Jeddah East Hospital project, Jeddah, KSA 2015- 2016.
He was awarded Arab Board (ABIM), Saudi Board (SBIM) & Membership of Royal College of Physician of Internal Medicine (MRCP, UK, oversea) certifications of Internal Medicine at 2001.I obtained the Fellowship of Royal College of Physician of Internal Medicine – Endocrine, (FRCP), UK, Edinburg, U.K, & Membership of Royal College of Physician of Endocrinology & Diabetes (MRCP,UK). He had more than 16 years’ experience of managing various types of endocrine disorders & diabetes He is currently the chief of executive committee of Saudi society of endocrinology & metabolism (SSEM) in Jeddah region, President of Gulf Association of Endocrinology and Diabetes (GAED) and President of Arab Thyroid Association (ArTA).
He is a Certified Professional in Health Care Quality (CPHQ) & awarded Professional Post Graduate Diploma in Healthcare & Hospital Management at from American university in Cairo.
He has authored and co-authored more than 25 articles. He has been invited to speak at several professional endocrine and diabetes meetings.
He is actively involved in organizing many local endocrine scientific activities. He is a member of many hospitals wide committees, local, regional & international scientific associations.
Professor of Pediatric Endocrinology,
Head, Pediatric Endocrinology & Diabetes section,
King Abdulaziz University Hospital
Abdulmoein Al-Agha is a Professor of Pediatrics & Pediatric Endocrinology & head of the pediatric endocrinology section at King Abdul Aziz University. He received his Fellowship certificate in Pediatric Endocrinology and Diabetes from Sydney, Australia. Fellowship of the Royal College of Physicians (Edinburg, and graduated from King Abdul Aziz University Medical School, Jeddah, Saudi Arabia.
He has many presents and past academic and administrative positions including; MRCPCH overseas examiner and host. He is a coordinator of, the Pediatric Club Western Region. He was the chairman of Reproductive Modules "New Faculty Curriculum". He is as well, a visiting Professor, at Ibn- Sina Medical School. He has been invited to be an external examiner in the united kingdom (London) and for many Gulf and Arab countries; including Bahrain, Kuwait, United Arab Emirates, Oman, and Egypt for Pediatric under and postgraduates as well as Endocrine examinations. He has been invited as a speaker for many local educational programs and conferences as well Gulf, Arab and international conferences. He developed an interest in medical education and he had a Certificate of medical education at the University of Illinois, Chicago, USA. In research, he has published 136 publications in refereed journals and orally presented more than 140 presentations in international meetings. He has also authored an English textbook on Pediatric Endocrinology and diabetes textbook and 12 Arabic books. Finally, he is a member of many Pediatric and Endocrine local and international societies.
Professor (Chair) of Internal Medicine, Chief Physician
Department of Nephrology
University of Helsinki and Helsinki University Hospital
Professor Per-Henrik Groop, MD, DMSc, FRCPE graduated from the University of Helsinki in 1982. It was here where he defended his thesis on ‘The relationship between GIP and beta-cell function in man’ in 1989. Following post-doctoral studies at Guy’s Hospital, University of London, under Professor Giancarlo Viberti, Professor Groop returned to Helsinki as Consultant of Nephrology. He served as Professor of Nephrology (Chair) 2010-2015 and is currently Professor of Internal Medicine (Chair) at the University of Helsinki. He is also Chief Physician at the Department of Nephrology, University of Helsinki and Helsinki University Hospital and Principal Investigator of the Finnish Diabetic Nephropathy (FinnDiane) Study at the Folkhälsan Research Center in Helsinki, Finland. He is Adjunct Professor at the Department of Diabetes, Monash University, Melbourne, Australia.
His research is focused on the dissection of the pathogenesis of diabetic complications with special emphasis on diabetic nephropathy. In order to provide a unique set of clinical resources with high power to identify genes and genetic variants associated with diabetic complications, Professor Groop initiated the large, nationwide FinnDiane Study in 1997. To date, this landmark study comprises 9000 patients with Type 1 Diabetes and their family members recruited via a comprehensive network of 92 hospitals and healthcare centres throughout Finland. His FinnDiane Research Group represents an inter-disciplinary team of 45 scientists, post-graduate students and personnel.
Professor Groop served as Associate Editor of Diabetologia, 2005–2007, and as member of the Advisory Board, 2008–2011. He was Associate Editor of Kidney International and International Diabetes Monitor, 2007–2011. He is currently on the Editorial Board of Diabetes Care. He was Chairman of the EASD Scientist Training Course, 2007–2013, President of the European Diabetic Nephropathy Study Group (EDNSG), 2008–2010, and Honorary Secretary of the EASD 2013-2016. He is since 2011 the chairman of the Signe and Ane Gyllenberg Foundation. He was awarded the prestigious EASD Castelli Pedroli Prize – 24th Camillo Golgi Lecture in 2009, the Novo Nordisk Foundation Lecture in 2012, and the IDF Award for Clinical and Therapeutic Research 2019.
Professor Groop has published more than 420 peer-reviewed original articles in high-impact journals, 35 reviews and book chapters, 50 papers in his native languages Swedish and Finnish as well as more than 700 abstracts presented at major international meetings.
President and Scientific Director
Hub for International health ReSearch HIRS
Special Advisor to the IDF Europe Board
Massimo Massi-Benedetti MD
Graduated in Medicine and specialized in Internal Medicine and in Endocrinology at the University of Perugia(I)
NATO Fellow at the University of Newcastle UT (UK)
Member of national and international professional and non professional diabetes associations,
Former positions: Faculty of Medicine of the University of Perugia: teaching courses of Internal Medicine and Endocrinology; Chair of the Schools of Podology and of Nursing Sciences; member of the Academic Senate. Chair of the Umbria Regional Diabetes Reference Centre; Co-director of the WHO Collaborating Centre for Diabetes Care Improvement. Director of Research and Education at Dasman Institute for Diabetes Research (Kuwait, 2007-2009). Chair of IDF Europe (1997- 2003), IDF-Global Vice-president (2003-2009), Chairman of the IDF Science TF (2009-2012). Founder of the Members of the European Parliament Diabetes Working Group. Co-chair of the International ICHOM Working Group for Diabetes Standard Set. Member of the European Union Diabetes Forum (EUDF) Working Group on Data and Registries.
At present: Chair of the EUBIROD Network. President of the HUB for International health ReSearch-HIRS. Chair of the Working Group on Value Based Health Care-VBHC of the Project on clinical and social frailties within the Italian Health Care System before, during and after Covid-19. Senior Adviser to the IDF Europe Board.
Main areas of research in diabetes: pathophysiology; new drugs; advanced systems for insulin delivery; complications; pregnancy; metabolic monitoring; epidemiology, diabetes registries; ethics. Partner of EU projects EURODIABETA; DIABCARD 1-4; DIABCARE 1-3; MFIT; DIABSTYLE 1-2; ADICOL, IMMIDIAB, PARENT, CHRODIS, BRIDGE Health and Project leader of B.I.R.O. and EUBIROD.
Ophthalmology Dept. of Istanbul Florence Nightingale Hospital
Dr. Karadeniz, an ophthalmologist, has been actively involved in a series of medical, scientific and social projects / programs both at national and international levels in the field of diabetes for the past 25 years.
She is the Founding Member, and Member of the Board of the Trustees of the Turkish Diabetes Foundation (TURKDIAB).
Dr. Karadeniz joined the board of International Diabetes Federation European Region (IDF Europe) in 2007, and served as the Chair of IDF Europe from Dec 2015 to Dec 2019.
Currently, she works as an ophthalmologist at the Ophthalmology Dept. of Istanbul Florence Nightingale Hospital. She is also a Teaching Faculty at the Ophthalmology Dept. of Faculty of Medicine, Demiroglu Bilim University.
She is a Board Member of the Turkish Diabetes Foundation (IDF Member since 1997), and also serves as the President of the Living with Diabetes Association, a nationwide patients’ organization.
MB, BS (Hons),
MD, DSc (hon),
FACP, FICP, FRCP
Professor Boulton is a graduate of Newcastle-upon-Tyne and subsequently trained in Sheffield, and Miami prior to accepting an appointment at Manchester University. He has authored more than 550 peer-reviewed manuscripts (H-Index >130) and book chapters, mainly on diabetic lower limb and renal complications.
Among his many awards, he has received the ADA’s Roger Pecoraro Lectureship, the EASD Camillo Golgi prize and was the first recipient of the international award on diabetic foot research. He was the 2008 winner of the ADA’s Harold Rifkin award for distinguished international service in diabetes. He received the 2012 Georgetown distinguished achievement award in diabetic limb salvage. In 2015 he visited Nagoya, Japan and gave a prize lecture on diabetic complications at the Japan Society of Diabetes, and in 2017 was the Banting Memorial Lecturer at Diabetes UK and also received the International Diabetes Endocrinologist Award of the year from the American Association of Clinical Endocrinologists.
A previous editor of Diabetic Medicine he is currently the senior associate editor of Diabetes Care.
In 2019 he was ranked the number one UK diabetes researcher in the field of complications.
He was the founding Chairman of the Diabetic Foot Study Group and was previously Chairman of Postgraduate Education and then Hon. Secretary/ programme chair for the EASD. Until late 2015 he was President of the EASD. Currently, President, International Diabetes Federation, and Chairman of EURADIA (European Alliance for Diabetes Research).
Professor Dr. Dr. h.c. Eberhard Standl FESC
Munich Diabetes Research Group e.V.
at Helmholtz Center
Munich - Neuherberg,
Dr. Eberhard Standl is Professor of Medicine, endocrinologist and angiologist at the Forschergruppe Diabetes eV. at Munich Helmholtz Centre. He graduated from the Universities of Munich and Frankfurt (1967), and has developed his career in both Munich, and at the Joslin Diabetes Center, Boston, USA. He is retired director of the Department of Endocrinology, Diabetology and Metabolism at the Academic Hospital Munich-Schwabing and of the Forschergruppe Diabetes eV.
Professor Dr. Standl's principal areas of research are diabetology, heart failure and diabetes, micro- and macro-vascular disease, cardio-neuropathy, muscle metabolism, action and degradation of insulin, immune pathogenesis of Type 1 diabetes, oxygen transport to tissue, epidemiology of cardiovascular diabetic complications and related randomized controlled intervention trials evaluating innovative blood glucose lowering drugs. He has published some 657 original papers, review articles, textbook chapters and monographs, and has received a wide range of scientific awards, including the Bertram Award of the German Diabetes Association for research related to vascular disease in diabetes in 1981, the Castelli-Pedroli Prize of the European Association for the Study of Diabetes (EASD) in 1999, the Harold Rifkin Award of the American Diabetes Association 2005, and the Albert Renold Medal of EASD 2006, as well as the Ernst-von-Bergmann Plaque of the German Chamber of Physicians 2002 and the Golden Ribbon of Honour of the Bavarian Internists 2004 for his long-term dedication to medical education. In December 2013, he received the Hellmut Mehnert Award for his lifetime achievement at the World Diabetes Congess of the International Diabetes Federation (IDF). He is a member of several scientific associations, with strong affiliations to the German Diabetes Association, the EASD, and IDF. He was President of the German Diabetes Association 1988/89, vice-President both of EASD and IDF 2003 to 2006 and chairman of the Organizing Committee for the EASD congress 2004 in Munich. Furthermore, he is Past-President both of the German Diabetes Union (2003 to 2008) and of IDF Europe (2007/08) and was co-chair of the Joint Task Force of EASD and ESC (European Society for Cardiology) for the Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases 2004 – 2009. Currently, he is vice chair of the EASD study group on diabetes and cardiovascular disease and serves as associate editor of Diabetes Research and Clinical Practice. 2010 he has been elected as Fellow of the European Society of Cardiology. He is an honorary member of multiple National Diabetes as well as Cardiology Societies and Associations.
Assistant Professor of Medicine
Consultant Endocrinology and Diabetes
College of Medicine and King Saud University Medical City
King Saud University
Dr. Abdullah Alguwaihes graduated from medical school of King Saud University and completed his Internal Medicine and Endocrinology training at University of Toronto then obtained Master of Public Health from Johns Hopkins University. He is currently Assistant Professor of Medicine at king Saud University and Consultant Endocrinologist at King Saud University Medical City and Dallah hospital. His interest revolves around type 1 diabetes, using technology to improve quality of life of patients with T1DM and long term complications of diabetes.
Associate Professor of Medicine
Dr. Westman is an Associate Professor of Medicine at Duke University. He is Board Certified in Obesity Medicine and Internal Medicine, and founded the Duke Keto Medicine Clinic with Dr. William S. Yancy Jr. in 2006 after 8 years of clinical research regarding low carbohydrate ketogenic diets.
He is Past-President and Master Fellow of the Obesity Medicine Association and Fellow of The Obesity Society. He is an editor of the textbook: Obesity: Evaluation & Treatment Essentials, and author of the New York Times Bestseller The New Atkins for a New You, Cholesterol Clarity, and Keto Clarity. He is co-founder of Adapt Your Life, an education and product company based on low carbohydrate concepts.
He is course coordinator for MED415c, a Fourth-Year Medical Student Elective on the Medical Management of Obesity, and a faculty member of the Duke Clinical Research Training Program.
Innovation and Analytics Expert
Abdullah Al Zakwani is an experienced academic and industrial expert in Data Science and Artificial Intelligence. He specializes in Intelligent Agent, a core branch of re-enforced and unsupervised learning techniques.
He is currently the Executive Director for Research and Innovation for Lamad LLC and Senior Researcher for Taqat LLC, and a visiting lecturer to various universities. Holding a PhD in AI and GIS and has taught as Senior Lecturer in various Universities in the United Kingdom with long appointment to University of East London as a Head of BSc and MSc Programs and units including Software development, Cyber Security, Mathematics and Artificial Intelligence.
Abdullah Al Zakwani has a strong background in Mathematics with a focus on GIS and statistical models. He has published various high scientific papers which resulted consultation to large organizations and his work has been used by NASA, Google, Apple to name a few.
Dr. Ali Al Lawati is an Internal Medicine specialist practicing in Oman,
He is currently working at the Diwan of Royal Court Health Complex . Prior to that, while working at the Royal Hospital in Muscat, he held the post of Acting Consultant in Acute Medicine and ran the Lifestyle Medicine clinic. He is also an expert in the Ketogenic diet, having been personally following it for 20 years.
He takes an active part in teaching medical residents and educating doctors on treatment of diabetes and other endocrine disorders. His strongest medical interests are in the fields of Lifestyle Medicine, Integrative Medicine and Endocrinology.
Consultant of Endocrinology and Diabetes
King Faisal Specialist Hospital and Research Center
Professor of Pediatrics and Endocrinology
College of Medicine, Al-Faisal University
Chief Medical Officer - Dasman Diabetes Institute
Consultant Diabetes, Endocrinology and Nutrition
Dr Ebaa Al Ozairi is the Chief Medical Officer at Dasman Diabetes Institute, a
consultant Diabetes, Endocrine and Nutrition. Dr Al Ozairi has completed her
intercalated BMSc (hons) in molecular pathology at Dundee University (UK) and
graduated from Aberdeen University (UK) for her medical undergraduate
studies. Ebaa then joined Newcastle University (UK) for her specialist training in
Diabetes and Endocrinology. During her postgraduate studies in UK, Dr Al Ozairi
was awarded The Fulbright fellowship to Joslin Diabetes Institute, affiliates of
Harvard medical school, Boston, USA.
Her research interest includes Nutrition, Obesity, Diabetes, Education, Technology and Metabolic Surgery.
Dr Ebaa Al Ozairi has completed her fellowship in obesity and holds the American Board for Physician Nutrition Specialist and is a fellow at the American College of Nutrition. She also directs DAFNE type 1 diabetes education program and currently granted the training center for the Middle East. Dr Al Ozairi has completed her Rabkin Fellowship in medical Education at Harvard Medical school. She is a reviewer for Lancet Endocrinology, European Journal for Endocrinology, Diabetic Medicine, Obesity, Surgery and Clinical Endocrinology.
Dr. Al Ozairi has 4 chapters in International books and an author in Medscape, bariatric times and Endodiabology and has more than 55 peer reviewed publications, in addition to more than 120 oral presentations in regional and international conferences. Dr Alozairi has won his highness the Amir Gold medal electronic award and the Arab regional award for e---technology for co--- founding the most comprehensive Arabic Diabetes Website. She was the 1st woman to become the president of American Association of Clinical Endocrinologist – Gulf Chapter.
Associate Professor, Weill Cornell Medicine
Senior Consultant, Family Medicine
Dr. Hashim Mohammad is an Associate Professor at Weill Cornell Medicine -Qatar and Senior Consultant of Family Medicine . He has graduated from the Royal College of Surgeons –Ireland in 1993.
He is a president of the Gulf Tissue Viability Group and Past Member of the European Association For The Study Of Diabetes, American Diabetes and American Association of clinical endocrinologists. Journal articles and abstracts by Dr. Mohamed have been published in numerous journals including Primary care Diabetes, Journal of Lymphoedema, Journal of diabetic foot complications , Singapore Medical Journal, Diabetology International and Dermatology Open Journal.
Dr Mohamed interests include the study of diabetes epidemiology and the diabetic foot , He has special interest in the use of Natural honey in the management of a variety of wounds including acute and chronic wounds such as diabetic foot ulcers ,varicose vein ulcers ,traumatic wounds, burns, cancer related wounds and various dermatological conditions including psoriasis , eczema and seborrheic dermatitis.
Dr Mohamed has presented scientific papers at international level including the USA, Italy and Malaysia. Dr Mohamed has a written a book on counseling named “ Evidence based counseling for helath care professionals “ and another one on wound management called “ Evidence based diabetic foot management at primary care level “ He has also Co-authored an educational toolkit named" Diabetes" and has written a chapter in a scientific book named "Cellular and biological mechanism of honey wound healing" . He is an associate editor in the Journal of Medical Case Reports ,Journal of Molecular &Genetic Medicine and Journal of Microbiology &Antimicrobials ,Dermatology Open Journal, Journal of Diabetes & Metabolism, etc.
Professor, Dubai Medical College
Consultant, Endocrinology | Diabetes | Islet Transplant
Diabetes Fellowship Program Director & Insulin Pump Section Head
Chairperson of the Diabetes Department
Obesity, Endocrine and Metabolism Center
King Fahad Medical City
Dr. Almehthel’s career started after completing his Bachelor’s Degree in Medicine and Surgery from King Abdulaziz University in Jeddah in 2001. In October of the same year, he joined King Faisal Specialist Hospital and Research Centre (KFSH & RC) in Riyadh as a Resident in Internal Medicine. He left to Canada in June 2004 and join the University of British Columbia (UBC) Residency Program in Internal Medicine, which he successfully completed in June 2007. Thereafter, he started his Fellowship Program in Endocrinology and Metabolism, which he completed in June 2009. At the same time, Dr. Almehthel obtained both the American Board and the Royal College of Physicians and Surgeons of Canada certifications in Internal Medicine and Endocrinology & Metabolism. He also completed a clinical and research fellowship in diabetes and islet transplantation between July 2009 and June 2011 at UBC.
In September 2011, He joined KFSH & RC as a consultant endocrinologist and served as the Endocrinology Postgraduate Program Director there from 2012 to 2014.
In February 2014, Dr. Almehthel went to Canada again, this time to join the UBC as a clinical associate professor in Endocrinology. He is also a transplant endocrinologist at Vancouver General Hospital (VGH) Islet Transplant Program and a staff endocrinologist at the Division of Endocrinology at both VGH and St. Paul’s Hospital (SPH). In October 2019, he was recruited to King Fahad Medical City where is working as a consultant endocrinologist, the head of the “Diabetes and Technology”, Diabetes Fellowship Program Director and chairperson of the diabetes department.
Dr. Almehthel’s research and clinical interests are diabetes, β-cell replacement therapy, diabetes technology and adrenal disorders. He has published many peer-reviewed abstracts, research papers and book chapters.
Dr. Noor Al Busaidi completed her Internal Medicine Residency Program as well as her Endocrinology Fellowship at the George Washington Medical Center and Veterans Affairs Medical Center in Washington DC, United States of America. She graduated from Sultan Qaboos University Medical School in Oman.
Since 2004 she worked as a Senior Consultant Physician at the Royal Hospital of Oman. Additionally, she was the Head of Endocrinology & Diabetes Department at the Royal Hospital of Oman from 2007 until 2010 and the Chairperson of the Clinical Audit Committee from 2008 to 2010. From 2010 until present, Dr. Al Busaidi has been appointed as the Chairperson of the National Diabetes Management Service Development Committee at the Ministry of Health of Oman. Furthermore, Dr. Al Busaidi is the founder and president of the Oman Diabetes Association and a member of the American Association for Clinical Endocrinology and American Diabetes Association.
She was involved in the Oman Medical Specialty Board as assistant program director for 3 years, program director for 2 year and as chairmen of internal medicine residency program for 2 years. Dr. Al Busaidi has been a keynote speaker and a lecturer at many national and international conferences. Her areas of interests include, but not limited to, Diabetes, Metabolic Syndrome, and Obesity with special focus on the improvement and implementation of healthy lifestyle that fights diabetes and Obesity pandemic.
She holds a degree in Medicine and Surgery from the Arabian Gulf University, the Arab Board and the Irish Board in Family Medicine from the University of Ireland and a Higher Diploma and a Master in Diabetes.
Dr. Rabaa Al-Hajri has been the Coordinator of Central Diabetes Clinics in Primary Health Care and Public Health and Chairman of the Board of Directors of Zallaq Health Center from 2010 to May 2015.
She is currently the Director of Dr. Rabaa Al-Hajri Center for Family Medicine and Diabetes and a lecturer at the Irish University / Bahrain Medical University.
Dr. Rabaa is a member of the Bahrain Diabetes Association and the Gulf Group for the Study of Diabetes.
The GGSD is a non-governmental, non-profitable, non-political group of medical and non-medical persons interested in research projects and launching educational programs related to diabetes care in Gulf Countries.
MCI Middle East United Arab Emirates
Tel: +971 4 311 6300
Fax: +971 4 311 6301